Treatment of recurrent ovarian cancer: intraperitoneal mitoxantrone plus vinorelbine i.v. versus mitoxantrone i.v plus vinorelbine i.v.
E. Cardamakis, P. Ginopoulos, D. Dimopoulos, E. Stathopoulos, M. Avaraki, G. Kourounis, V. TzingounisVolume:
35
Year:
1999
Language:
english
DOI:
10.1016/s0959-8049(99)81384-7
File:
PDF, 157 KB
english, 1999